Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 214,763 shares of the semiconductor company's stock, valued at approximately $104,237,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.14% of Synopsys at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in SNPS. Ameriflex Group Inc. bought a new position in Synopsys in the 4th quarter valued at about $29,000. Whipplewood Advisors LLC bought a new position in Synopsys in the fourth quarter valued at approximately $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Synopsys during the fourth quarter valued at approximately $34,000. Sierra Ocean LLC bought a new stake in Synopsys during the fourth quarter worth $39,000. Finally, Hazlett Burt & Watson Inc. boosted its holdings in shares of Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after purchasing an additional 20 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts have issued reports on SNPS shares. Needham & Company LLC reiterated a "buy" rating and issued a $650.00 target price on shares of Synopsys in a research report on Thursday, February 27th. Rosenblatt Securities reissued a "buy" rating and set a $660.00 price objective on shares of Synopsys in a report on Tuesday, February 25th. Piper Sandler lowered their target price on Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Mizuho cut their price target on Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. Finally, Morgan Stanley lowered their price objective on Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research note on Monday, February 24th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Synopsys has an average rating of "Moderate Buy" and an average target price of $614.86.
Read Our Latest Stock Report on Synopsys
Synopsys Stock Down 9.6%
SNPS traded down $49.36 during trading on Wednesday, reaching $462.43. 4,790,448 shares of the stock traded hands, compared to its average volume of 1,121,537. The stock's 50-day moving average is $453.45 and its 200 day moving average is $487.42. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80. The stock has a market capitalization of $71.50 billion, a PE ratio of 31.85, a P/E/G ratio of 3.23 and a beta of 1.16.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 20.48% and a net margin of 36.12%. During the same quarter in the previous year, the company earned $3.00 earnings per share. The firm's revenue was up 10.3% on a year-over-year basis. As a group, equities research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This represents a 13.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Geus Aart De sold 15,705 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the sale, the insider now directly owns 116,671 shares of the company's stock, valued at $51,850,925.82. This trade represents a 11.86% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by corporate insiders.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.